1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

Clicks: 560
ID: 115513
1997
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
This is the first in a series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of these guidelines is to provide assistance to clinicians when making decisions on treating the conditions specified in each guideli …
Reference Key
wt1997clinical1997 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hughes WT;Armstrong D;Bodey GP;Brown AE;Edwards JE;Feld R;Pizzo P;Rolston KV;Shenep JL;Young LS;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 1997
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/9314442
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine adult Child neoplasms / drug therapy time factors drug therapy neutropenia / complications* practice guideline antineoplastic agents / adverse effects fever of unknown origin / drug therapy* neutropenia / chemically induced guideline neutropenia / drug therapy* bacterial infections / complications combination / therapeutic use anti-bacterial agents / therapeutic use* anti-bacterial agents / economics cost-benefit analysis bacterial infections / drug therapy antiviral agents / therapeutic use pmid:9314442 doi:10.1086/513764 w t hughes d armstrong l s young colony-stimulating factors / therapeutic use fever of unknown origin / complications* granulocytes / transplantation

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.